Please login to the form below

Not currently logged in
Email:
Password:

New member for Millennium Pharmaceuticals board

Millennium Pharmaceuticals has elected Dr Jeffrey M Leiden to its board of directors.

Millennium Pharmaceuticals has elected Dr Jeffrey M Leiden to its board of directors.

Dr Leiden, currently managing director at life sciences venture capital firm, Clarus Ventures, has over 20 years of experience in the biomedical and pharmaceutical sectors.

Prior to joining Clarus, Leiden served as President and COO of the global Pharmaceutical business of US pharmaceutical company, Abbott Laboratories.

Before joining Abbott in 2000, Leiden was the Elkan R Blout professor of biological sciences at Harvard School of Public Health, as well as professor of medicine at Harvard Medical School. Before his career at Harvard, he served as professor of medicine and pathology and chief of cardiology at the University of Chicago, School of Medicine. Leiden has also co-founded several biotechnology firms.

"It is a pleasure to have Dr Leiden join the Millennium Board of Directors," said Deborah Dunsire, Millennium's CEO, "We believe his diverse pharmaceutical and scientific experience will enable him to help guide our continued growth and success in our mission of delivering vital medicines to patients."

Leiden joins as an independent director and brings the number of Millennium board members to ten.

30th September 2008

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...
A snapshot of… Exscientia
...

Infographics